María Teresa Herrera-Abreu

Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer

María Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar et al. · Cancer Research · 2016 · 742 citations · Full text

Pi3k Inhibitors, Breast Oncology, Estrogen Receptor +19

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer

Uzma Asghar, Alexis R. Barr, Ros Cutts et al. · Clinical Cancer Research · 2017 · 274 citations · Full text

High-Level Clonal <i>FGFR</i> Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

Alex Pearson, Elizabeth Smyth, Irina S. Babina et al. · Cancer Discovery · 2016 · 259 citations · Full text

Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration

Siau Wei Baï, María Teresa Herrera-Abreu, Jennifer Rohn et al. · BMC Biology · 2011 · 215 citations · Full text

FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both <i>In Vitro</i> and <i>In Vivo</i>

Rachel Sharpe, Alex Pearson, María Teresa Herrera-Abreu et al. · Clinical Cancer Research · 2011 · 165 citations · Full text